"Insights into Global Cancer Supportive Care Drugs Market Growth"
The Cancer Supportive Care Drugs Market was estimated at US$ 20.9 billion in 2021 and is expected to grow at a CAGR of 2.04% during 2022-2028 to reach US$ ~21.40 billion in 2028.
The major players in the cancer supportive care drugs market are Amgen, Inc., F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc (GSK), Helsinn Healthcare SA, Heron Therapeutics, Inc., Johnson & Johnson Services, Inc., Merck & Co., Inc., Novartis AG.